{
    "nctId": "NCT04692168",
    "briefTitle": "Influence of Chemotherapy on Postural Control in Women With Cancer",
    "officialTitle": "Influence of Chemotherapy on Postural Control and Quality of Life in Women With Gynaecological Cancer: a Prospective Observational Study",
    "overallStatus": "COMPLETED",
    "conditions": "Cancer, Breast, Cancer, Gynecologic",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 35,
    "primaryOutcomeMeasure": "Change from baseline : postural control under various conditions.",
    "eligibilityCriteria": "Inclusion Criteria:\n\nWomen\n\n* between 18 and 65 years;\n* with a gynaecological cancer about to start chemotherapy known to be neurotoxic (paclitaxel, docetaxel, nab-paclitaxel, or paclitaxel-carboplatin);\n* able to stand upright for 30 s on a flat surface without assistance;\n* able to provide written consent\n\nExclusion Criteria:\n\nWomen\n\n* with pre-existing vestibular, uncorrectable visual, or somatosensory disorders or other pathologies altering postural control that would influence testing;\n* with exposure to known neurotoxic chemotherapy (paclitaxel, docetaxel, nab-paclitaxel, vinorelbine, trastuzumab-emtansine, eribulin, or paclitaxel-carboplatin) that may have caused previous CIPN;\n* with an inability to perform the test due to poor comprehension of instructions or psychological problems.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}